Prognostic analysis of lung adenocarcinoma based on cancer-associated fibroblasts genes using scRNA-sequencing
Figure 9.A drug sensitivity analysis. (A) Drugs with higher sensitivity in the low-risk group. (B) Drugs with higher sensitivity in the high-risk group.